Directors and Officers Insurance Arrangements Before Listing: What to Consider

The Hong Kong market has entered a period of heightened director liability exposure, driven by a convergence of regulatory enforcement and class action mechanics. The SFC’s 2024-25 annual report recorded 194 active investigations and 74 disciplinary actions, a volume that has placed directors’ personal assets firmly in the crosshairs. Concurrently, the HKEX’s 2024 consultation on enhanced corporate governance disclosure (concluded in Q1 2025) introduced stricter requirements for board accountability on ESG and internal controls, expanding the scope of potential claims. For companies preparing for a Main Board or GEM listing, the directors’ and officers’ (D&O) insurance policy is no longer a routine administrative purchase. It is a structural risk-management decision that must be negotiated before the prospectus is filed, because post-listing premium volatility and coverage exclusions can materially affect a board’s willingness to serve. The following analysis outlines the specific considerations for pre-IPO D&O arrangements, drawing on Hong Kong’s regulatory framework and prevailing market practice.

The Pre-IPO Policy: Timing, Coverage, and the Listing Rule Interface

The window between engaging a sponsor and filing the A1 application is the optimal period to secure D&O coverage. Insurers assess risk based on the company’s historical compliance record, the complexity of its PRC or offshore structure, and the industry sector’s litigation profile. A policy bound after the prospectus is published will incorporate the heightened risk of the public offering period, often resulting in a 25-35% premium uplift relative to a pre-filing placement.

Placement Before the A1 Submission

The HKEX Listing Rules do not mandate D&O insurance for Main Board or GEM issuers, but the Corporate Governance Code (Appendix C1, Code Provision E.1.5) recommends that listed companies arrange appropriate insurance cover for directors and officers. For pre-IPO companies, the practical necessity is stronger. Sponsors and legal advisers will typically require evidence of a binding D&O policy as part of the due diligence process, confirming that the board is protected against claims arising from the prospectus and the listing process itself.

A standard pre-IPO D&O policy should include a “run-off” or “tail” cover of at least six years from the listing date. This aligns with the six-year limitation period under the Securities and Futures Ordinance (Cap. 571, s. 281) for market misconduct claims and the common law limitation period for breach of fiduciary duty. Without a run-off clause, directors who resign post-listing would lose coverage for acts committed during their tenure, exposing them to personal liability.

Coverage Exclusions Specific to the Listing Process

Insurers in the Hong Kong market routinely exclude claims arising from the IPO prospectus if the policy is bound after the prospectus is finalised. The rationale is that the prospectus represents a known risk event. To avoid this gap, the policy should be bound with a “prospectus coverage” endorsement that explicitly covers misstatements or omissions in the listing document, subject to a separate sub-limit. Typical sub-limits range from HKD 5 million to HKD 20 million for a Main Board IPO, depending on the company’s market capitalisation.

Another critical exclusion is for claims arising from regulatory investigations that were underway at the policy inception date. The SFC’s 2024 enforcement report noted that 38% of its investigations involved pre-IPO conduct, including undisclosed connected transactions and false financial statements. A pre-IPO company must disclose any pending SFC or HKMA inquiries to the insurer during underwriting; failure to do so can render the entire policy voidable for non-disclosure.

The Side A, B, C Structure and Pre-IPO Companies

D&O policies in Hong Kong are structured as Side A (director-only cover when the company cannot indemnify), Side B (company reimbursement for indemnified losses), and Side C (entity cover for securities claims). For a pre-IPO company, Side C is the most contentious. Insurers are reluctant to provide entity cover before listing because the company has no public trading history and the risk of securities class actions is unquantifiable.

The prevailing market practice is to bind a policy with Side A and Side B only during the pre-IPO phase, with a commitment from the insurer to add Side C upon listing, subject to a fresh underwriting review. This arrangement should be documented in a “binding letter of intent” signed by the insurer, specifying the conditions for Side C activation. Without this letter, the company may face a coverage gap on the first day of trading.

Cross-Border Structures and Insurer Risk Appetite

Hong Kong-listed companies with PRC operating entities through a VIE or contractual arrangement face additional underwriting scrutiny. The SFC and HKEX’s joint statement on VIE structures (September 2024) reiterated that directors owe fiduciary duties to the Hong Kong-listed issuer, not to the PRC operating entity. This creates a jurisdictional tension: a claim against a director for mismanagement of the PRC subsidiary may not be covered if the policy’s territorial clause limits coverage to Hong Kong law.

Territorial Clauses and PRC Risk

Standard D&O policies issued in Hong Kong typically cover claims brought in any jurisdiction, but with a “worldwide coverage” clause that excludes PRC regulatory actions unless specifically endorsed. The PRC’s Securities Law (2019 revision, effective March 2020) introduced a statutory cause of action for investors against directors of PRC-incorporated companies. For a Cayman-incorporated Hong Kong-listed issuer with a PRC VIE, a PRC regulatory investigation into the VIE’s operations could trigger a derivative claim in Hong Kong that falls outside the policy’s territorial scope.

The solution is a “PRC regulatory endorsement” that extends coverage to claims arising from PRC administrative or criminal proceedings, subject to a separate aggregate limit. The Hong Kong Federation of Insurers’ 2024 market survey found that only 23% of D&O policies for Hong Kong-listed PRC companies included such an endorsement. Pre-IPO companies with a PRC nexus should negotiate this endorsement as a condition of binding.

Multiple Jurisdiction Directorships

A pre-IPO board often includes directors who also serve on the boards of BVI or Bermuda subsidiaries, or who are appointed to the boards of PRC joint venture partners. The D&O policy must specify whether these “outside entity” positions are covered. Most standard policies exclude coverage for directorships in non-listed entities unless they are wholly-owned subsidiaries of the insured company. The HKEX’s Listing Rule 3.09 requires directors to satisfy the exchange of their competence and integrity, but it does not require the company to insure them for non-listed roles.

To address this, the policy should include a “subsidiary director endorsement” that extends coverage to all entities in which the listed issuer holds a controlling interest, defined as >50% equity or de facto control under the HKEX’s guidance on “control” (HKEX Guidance Letter GL89-16). For non-controlled joint ventures, a separate “outside directorship liability” policy may be necessary.

The IPO Prospectus and the Duty of Disclosure

The prospectus must disclose the existence and key terms of the D&O insurance policy. This is not a statutory requirement under the Companies Ordinance (Cap. 622) or the Listing Rules, but it is standard practice under the SFC’s Code of Conduct for persons licensed by or registered with the SFC (paragraph 16.2), which requires disclosure of all material contracts. A D&O policy is a material contract because its terms affect the board’s risk appetite and the company’s ability to retain directors.

Disclosure in the Prospectus

The disclosure should include the policy’s aggregate limit, the premium amount (if material), and any significant exclusions. The HKEX’s 2023 review of prospectus disclosures (published in January 2024) found that 41% of Main Board IPO prospectuses failed to disclose the D&O policy premium, and 28% omitted the policy’s territorial scope. This is a deficiency that the SFC may query during its prospectus review under the Securities and Futures (Stock Market Listing) Rules (Cap. 571V, s. 5).

The recommended practice is to include a dedicated section in the prospectus’s “Directors and Senior Management” chapter, stating the policy limit, the insurer’s name, the policy period, and a summary of key exclusions. If the policy contains a “fraud exclusion” (which voids coverage for fraudulent acts), the prospectus should state that coverage is subject to a final adjudication of fraud by a court, not merely an allegation.

The Sponsor’s Role in Policy Verification

The sponsor is responsible under the SFC’s Code of Conduct (paragraph 17.6) for verifying that the company has adequate insurance for its directors. This is not a passive check. The sponsor should obtain a copy of the binding policy or the binding letter of intent, confirm that the policy’s inception date precedes the prospectus filing date, and verify that the run-off period meets the six-year standard. The sponsor’s due diligence file should include a legal opinion from the company’s Hong Kong counsel confirming that the policy does not contain any exclusion that would materially impair the directors’ protection.

Post-Listing Premium Volatility and Renewal Strategy

The D&O insurance market in Hong Kong has experienced a hardening cycle since 2022, with average premium increases of 15-20% per annum for listed companies, according to Marsh’s 2025 Hong Kong D&O Market Update. For a newly listed company, the first post-IPO renewal is the highest risk. The insurer will reassess the company’s claims history, share price volatility, and any regulatory actions during the first year of listing.

The First Renewal: A Pricing Shock

A company that listed with a premium of HKD 800,000 per annum for a HKD 50 million aggregate limit may face a first-renewal premium of HKD 1.2 million to HKD 1.4 million, assuming no claims. This increase is driven by the insurer’s need to price the “tail risk” of the IPO period, which is only fully known after the first year of trading. The HKEX’s 2024 annual report noted that 12% of newly listed companies experienced a share price decline of >50% within the first six months of trading, a trigger for securities class actions in the US and, increasingly, in Hong Kong under the statutory cause of action in the Securities and Futures Ordinance (Cap. 571, Part XIII).

To mitigate this volatility, the pre-IPO policy should include a “multi-year premium guarantee” clause, locking the premium for the first three policy years. This is available from a limited number of insurers (primarily Lloyd’s syndicates and A-rated carriers), but it is a standard negotiating point for companies with a market capitalisation above HKD 1 billion.

Claims-Made vs. Occurrence Basis

All D&O policies in Hong Kong are written on a claims-made basis, meaning coverage is triggered only if a claim is made during the policy period. For a pre-IPO company, this creates a risk: a claim arising from a pre-listing act but made after the policy expires (and after the run-off period ends) will not be covered. The solution is to negotiate an “extended reporting period” (ERP) of at least 12 months after the policy’s expiration, during which any claim arising from a pre-listing act is automatically covered. The ERP should be non-cancellable by the insurer and should not require an additional premium.

Actionable Takeaways

1. Bind the D&O policy before the A1 submission to lock in a lower premium and secure a prospectus coverage endorsement with a sub-limit of at least HKD 10 million for Main Board applicants.
2. Negotiate a PRC regulatory endorsement for any company with a VIE or PRC operating subsidiary, as standard territorial clauses exclude PRC administrative and criminal proceedings.
3. Disclose the policy’s aggregate limit, premium, and key exclusions in the prospectus’s “Directors and Senior Management” section to satisfy the SFC’s Code of Conduct and avoid a deficiency query.
4. Obtain a binding letter of intent from the insurer committing to add Side C entity cover upon listing, with specific conditions for activation, to prevent a coverage gap on the first trading day.
5. Include a multi-year premium guarantee clause in the pre-IPO policy to cap post-listing premium increases at no more than 10% per annum for the first three years, mitigating the first-renewal pricing shock.